Foresight Diagnostics, a leader in ultra-sensitive minimal residual disease (MRD) detection technology, today announced the inclusion of circulating tumor DNA (ctDNA) testing in the National ...
MUNSTER Rugby have made three changes to the side that will face Saracens in the third group game of the Investec Champions ...
Toulouse captain Antoine Dupont on Friday "questioned the logic" behind South African sides playing in the Champions Cup ...
Multiple TIGIT clinical data readouts anticipated throughout 2025, including >400 patients from two Phase 2 trials and one Phase 1/2 ...
With two games left to conclude the first round of UEFA Champions League 2024-25, we take a deep dive into which teams the ...
After 34 years the iconic Day of Champions has come to an end. After a new schedule for the 2025 British Grand Prix has been ...
Dr. Buchanan will helm Belharra’s research organization as the company progresses its lead immunology and oncology programs, advances activities with its pharma collaborators, and enriches its ...
MarketBeat on MSN1h
Zymeworks in Focus for Insider Activity: Catalysts AheadZymeworks (NYSE: ZYME) came into focus in late December when major shareholder EcoR1 Capital increased its stake. Already a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback